Brief: Renovorx Reports Third Quarter 2022 Financial Results
14/11/2022 18:26
Nov 14 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* RENOVORX INC - QTRLY NET LOSS WAS $2.1 MILLION FOR QUARTER
ENDED
ON SEPTEMBER 30, 2022
Source text for Eikon: ID:nBw5YCTGHa
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies